SUBSCRIBE
SUBSCRIBE

Publix Follows Guidance and Suspends Administration of Johnson & Johnson COVID-19 Vaccine

April 13, 2021 | 
1 min read

Following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), Publix is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations.

LAKELAND, Fla.--(BUSINESS WIRE)-- Following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA), Publix is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations.

Customers can visit publix.com/covidvaccine to schedule an appointment for the Moderna COVID-19 vaccine, if currently available in their state.

The CDC and FDA have issued a joint media statement with additional information about the Johnson & Johnson COVID-19 vaccine. According to the CDC and FDA, while a rare side effect, individuals who have received the Johnson & Johnson COVID-19 vaccine should contact their health care provider if they develop a severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination.

Publix, the largest employee-owned company in the U.S. with more than 225,000 associates, currently operates 1,270 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia. For 24 consecutive years, the company has been recognized by Fortune as a great place to work. In addition, Publix’s dedication to superior quality and customer service is recognized among the top in the grocery business. For more information, visit the company’s website, corporate.publix.com.

Contacts

Maria Brous
(863) 680-5339

Source: Publix